String Vessel Formation is Increased in the Brain of Parkinson Disease.
暂无分享,去创建一个
Mike Dragunow | R. Faull | M. Dragunow | B. Synek | H. Waldvogel | J. Guan | Jian Guan | Darja Pavlovic | Clinton Turner | Panzao Yang | Henry Waldvogel | Beth Synek | Richard Faull | C. Turner | Panzao Yang | D. Pavlovic
[1] H. Shill,et al. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects , 2012, Neurological research.
[2] N. Narayanan,et al. Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease , 2013, Reviews in the neurosciences.
[3] S. Kawamoto,et al. Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors* , 2009, The Journal of Biological Chemistry.
[4] A. Guha,et al. Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis , 2000, Brain Research.
[5] C. Green,et al. Vascular Degeneration in Parkinson's Disease , 2013, Brain pathology.
[6] David R. Croucher,et al. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions , 2014, Brain Research.
[7] Chiao-Chi V. Chen,et al. Neurovascular abnormalities in humans and mice with Huntington's disease , 2013, Experimental Neurology.
[8] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[9] D. Choi,et al. Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease , 2013, Mediators of inflammation.
[10] W. Brown. A review of string vessels or collapsed, empty basement membrane tubes. , 2010, Journal of Alzheimer's disease : JAD.
[11] Amity E. Green,et al. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.
[12] W. Poewe. Treatments for Parkinson disease—past achievements and current clinical needs , 2009, Neurology.
[13] Andrew King,et al. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium , 2008, Brain pathology.
[14] J. C. Torre. Alzheimer's disease: how does it start? , 2002 .
[15] G. Paxinos,et al. Evidence for plasticity of the dopaminergic system in Parkinsonism , 2008, Molecular Neurobiology.
[16] Andrew King,et al. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium , 2009, Acta Neuropathologica.
[17] B. H. Choi,et al. Role of the basement membrane in neurogenesis and repair of injury in the central nervous system , 1994, Microscopy research and technique.
[18] P. Tresco,et al. Astrocytes specifically remove surface-adsorbed fibrinogen and locally express chondroitin sulfate proteoglycans. , 2013, Acta biomaterialia.
[19] Y. Koyama,et al. Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. , 2012, Journal of pharmacological sciences.
[20] C. Agulhon,et al. Recent molecular approaches to understanding astrocyte function in vivo , 2013, Front. Cell. Neurosci..
[21] P. Yurchenco. Basement membranes: cell scaffoldings and signaling platforms. , 2011, Cold Spring Harbor perspectives in biology.
[22] Marwan N. Sabbagh,et al. Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease , 2012, PloS one.
[23] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[24] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[25] P. Carmeliet,et al. PIGF Knockout Delays Brain Vessel Growth and Maturation upon Systemic Hypoxic Challenge , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] William J. Brunken,et al. Laminins containing the β2 and γ3 chains regulate astrocyte migration and angiogenesis in the retina , 2013, Development.
[27] S. P. Hunt,et al. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea , 1988, Neuroscience.
[28] S. Strickland,et al. Fibrinogen and altered hemostasis in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[29] J. Haorah,et al. Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.
[30] J. Ryu,et al. A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.
[31] R. Macdonald,et al. Vascular aspects of neuroprotection , 2004, Neurological research.
[32] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[33] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[34] K. Baer,et al. Immunohistochemical staining of post-mortem adult human brain sections , 2006, Nature Protocols.
[35] D B Calne,et al. Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. , 1991, Archives of neurology.
[36] Andrew King,et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. , 2009, Acta neuropathologica.
[37] T. Joh,et al. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.
[38] D. Oorschot,et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. , 2010, Brain : a journal of neurology.